BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27956387)

  • 21. Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.
    Poitevin S; Cussac D; Leroyer AS; Albinet V; Sarlon-Bartoli G; Guillet B; Hubert L; Andrieu-Abadie N; Couderc B; Parini A; Dignat-George F; Sabatier F
    Cardiovasc Res; 2014 Jul; 103(1):121-30. PubMed ID: 24743591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting sphingosine kinase-1 to inhibit melanoma.
    Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
    Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
    Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate cell migration.
    Maceyka M; Alvarez SE; Milstien S; Spiegel S
    Mol Cell Biol; 2008 Sep; 28(18):5687-97. PubMed ID: 18644866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia.
    Meng H; Yuan Y; Lee VM
    PLoS One; 2011; 6(11):e27150. PubMed ID: 22096531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.
    Kharel Y; Mathews TP; Gellett AM; Tomsig JL; Kennedy PC; Moyer ML; Macdonald TL; Lynch KR
    Biochem J; 2011 Dec; 440(3):345-53. PubMed ID: 21848514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis.
    Yang L; Yue S; Yang L; Liu X; Han Z; Zhang Y; Li L
    J Hepatol; 2013 Jul; 59(1):114-23. PubMed ID: 23466305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells.
    Böhm A; Flößer A; Ermler S; Fender AC; Lüth A; Kleuser B; Schrör K; Rauch BH
    Cardiovasc Res; 2013 Aug; 99(3):505-13. PubMed ID: 23658376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
    Edmonds Y; Milstien S; Spiegel S
    Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal.
    Gude DR; Alvarez SE; Paugh SW; Mitra P; Yu J; Griffiths R; Barbour SE; Milstien S; Spiegel S
    FASEB J; 2008 Aug; 22(8):2629-38. PubMed ID: 18362204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
    Kono Y; Nishiuma T; Nishimura Y; Kotani Y; Okada T; Nakamura S; Yokoyama M
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):395-404. PubMed ID: 17641298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine kinase 1 in viral infections.
    Carr JM; Mahalingam S; Bonder CS; Pitson SM
    Rev Med Virol; 2013 Mar; 23(2):73-84. PubMed ID: 22639116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
    Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells.
    Lan T; Liu W; Xie X; Xu S; Huang K; Peng J; Shen X; Liu P; Wang L; Xia P; Huang H
    Mol Endocrinol; 2011 Dec; 25(12):2094-105. PubMed ID: 21998146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.
    Thomas D; Powell JA; Vergez F; Segal DH; Nguyen NY; Baker A; Teh TC; Barry EF; Sarry JE; Lee EM; Nero TL; Jabbour AM; Pomilio G; Green BD; Manenti S; Glaser SP; Parker MW; Lopez AF; Ekert PG; Lock RB; Huang DC; Nilsson SK; Récher C; Wei AH; Guthridge MA
    Blood; 2013 Aug; 122(5):738-48. PubMed ID: 23775716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
    Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
    Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
    Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
    Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.